Navigation Links
Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Date:9/17/2007

ber 20 at 10:00 AM, Room E253D:

-- Poster F1-2116, titled "In vitro Activity of REP8839 against

Pasteurella species and Other Fastidious Bacteria Isolated from

Infected Animal Bites in Humans."

About Clostridium difficile

C. difficile is a Gram-positive anaerobic bacterium that causes C. difficile-associated disease (CDAD). CDAD is on the rise worldwide, both in terms of number of cases and severity of the disease. Most cases of CDAD occur in a hospital setting due to increased use of antibiotics and other chemotherapeutics that disrupt normal intestinal flora, an ageing population, and difficulty of eradicating C. difficile spores. However, more recently, CDAD has been acquired in the community setting where several outbreaks with increased mortality have occurred. The emergence of an epidemic, hypervirulent C. difficile strain (BI/NAP1, 027) that produces high levels of toxins poses a real threat to public health and demands improved infection control as well as novel treatment options.

About Replidyne, Inc.

Replidyne is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing innovative anti-infective products. Replidyne's lead product, faropenem medoxomil, is a novel oral, community antibiotic, expected to be appropriate for use as a first-line antibiotic for treatment of respiratory and skin infections in adult and pediatric patients. Replidyne's second drug candidate, REP8839, is a topical anti-infective product candidate in development for the treatment of skin and wound infections, including methicillin-resistant S. aureus (MRSA) infections. Replidyne's investigational antibacterial agent REP3123 targets Gram-positive C. difficile bacteria and related diseases. In preclinical studies, REP3123 has been show to inhibit growth, toxin production and spore-forming in C. difficile bacteria. Replidyne is also pursuing the development of other novel anti-infective programs bas
'/>"/>

SOURCE Replidyne, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Replidyne Announces Positive Phase I Results for Topical Antibiotic REP8839
2. $30 M Aid in the pipeline by WB for bird flu in Turkey
3. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
4. Battery power from viruses in the pipeline
5. Effective Vaccine for Leishmaniasis in the Pipeline
6. Home Test Kit for AIDS in the Pipeline
7. Sensing Devices to Measure Sleep In the Pipeline
8. Blood Fluke Vaccine in the Pipeline
9. Chlamydial Vaccine for Humans in the Pipeline
10. New Treatment Option in the Pipeline for Those Suffering From Lung Cancers
11. Treatment of Endometriosis in the Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Pa. (PRWEB) May 04, 2015 Sylvia Hawthorn-Deppen ... the hopes that it would remind others in similar situations ... A Recovery from Chronic Pain and Discovery of New Energy” ... with a new audience via a renewed press campaign. , ... with debilitating pain ,” Hawthorn-Deppen says. “As an adolescent ...
(Date:5/4/2015)... CA (PRWEB) May 04, 2015 Fast ... Eric Gladen’s documentary Trace Amounts, and Allison Folmar, JD, ... autism conference held internationally. , On Sunday, May 24, ... recovery from autism possible?" Are you interested in Ryan ... In There: winning our war against autism was ...
(Date:5/4/2015)... Angeles, California (PRWEB) May 04, 2015 ... a physician practice management firm in Los Angeles ... announced today the patent-pending status of The Sara Soulati ... by Soulati in 2010, is a lifestyle modification and ... in April 2015 to the U. S. Patents and ...
(Date:5/3/2015)... Leading international program provider, Child Family ... the 2015 Harris Wofford Global Service Fellowships. CFHI Global ... deserving recipients of the award named after former US ... The two recipients were chosen for their strong commitment ... , CFHI is one of seven organizations participating in ...
(Date:5/3/2015)... Mateo, CA (PRWEB) May 03, 2015 ... service, MnemeTherapy® at two upcoming area seminars. The first ... the PSA Annual Regional Stroke Conference to be held ... be offered on Wednesday, May 13 during the Dementia ... Plaza. , “These seminars offer an excellent opportunity ...
Breaking Medicine News(10 mins):Health News:Author launches new press campaign for 2012 book ‘Wheel’ 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 4Health News:CEO Sara Soulati Announces Patent-Pending Designation For The Sara Soulati Health For Life Program 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 3Health News:NuevaCare Introduces MnemeTherapy® Approach to Care for Elderly Patients with Alzheimer’s, Stroke and Other Types of Neurodegenerative Conditions 2
... studies examining the effects of stem cell source and patient ... a press conference taking place on Sunday, December 7, at ... Society of Hematology in San Francisco, CA. Preliminary results from ... of stem cells in cord blood for transplantation will also ...
... Contract negotiations between,the Ohio Nurses Association (ONA) and University ... the 6th session of,negotiations on Friday, December 5. To ... , At issue ... premiums. University Hospitals Geneva has indicated that they will,remove ...
... Americans need to re-learn proper serving sizes for meals, ... super-sized meals and cavernous drinks may help keep your ... waistline. , Nutrition experts say portion control is one ... Americans aren,t very good at recognizing reasonable portion sizes ...
... tool that will not cut the user or damage contents.This revolutionary new tool ... attacks. Tha Klever Kutter is a tool not a weapon; it is simply ... contents of the boxes being opened. The tool is simple in design, ... ...
... largest study ever to examine the preventive use of ... patients with cancer undergoing chemotherapy will be presented ... 9:30 a.m., during the 50th Annual Meeting of the ... research being featured at the press conference includes studies ...
... use of dexamethasone early in the treatment of children ... childhood cancer, may help reduce the risk of relapse ... conference on Saturday, December 6, at 2:00 p.m., during ... Hematology in San Francisco, CA. Additional research will be ...
Cached Medicine News:Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 2Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 3Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 4Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 5Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 6Health News:University Hospitals Geneva Medical Center Registered Nurses to Strike on December 10 if Contract Agreement Cannot Be Reached 2Health News:Portion Distortion 2Health News:Portion Distortion 3Health News:Revolutionary New Safety Cutter Patented After 911 Terrorist Attacks Is Changing the Way Boxes Are Opened 2Health News:Research highlights new approaches to prevent blood clots 2Health News:Research highlights new approaches to prevent blood clots 3Health News:Research highlights new approaches to prevent blood clots 4Health News:Research highlights new approaches to prevent blood clots 5Health News:Research highlights new approaches to prevent blood clots 6Health News:Research highlights new approaches to prevent blood clots 7Health News:Research highlights new approaches to prevent blood clots 8Health News:Novel treatments show improvements in survival and response rates for leukemia and lymphoma 2Health News:Novel treatments show improvements in survival and response rates for leukemia and lymphoma 3Health News:Novel treatments show improvements in survival and response rates for leukemia and lymphoma 4Health News:Novel treatments show improvements in survival and response rates for leukemia and lymphoma 5Health News:Novel treatments show improvements in survival and response rates for leukemia and lymphoma 6
(Date:5/4/2015)... JUNCTION, N.J. , May 4, 2015 /PRNewswire/ ... care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine ... in multiple countries worldwide, will report Q1 2015 ... May 11, 2015.  CytoSorbents, management ... webcast that will recount both operational and financial ...
(Date:5/4/2015)... -- Concord Medical Services Holdings Limited ("CCM" or the "Company") ... provider and operator of the largest network of radiotherapy and ... today that an Extraordinary General Meeting ("EGM") will be held ... time) at CCM,s office at 18/F, Tower A, ... District, Beijing, P.R. China . ...
(Date:5/4/2015)... /PRNewswire/ - YOLO Medical Inc. , ("YOLO") ... of medical and aesthetic devices, proudly announces that ... new generation body contouring laser system; LIPOFINA. ... low-level laser device for body contouring, creating and ... technology while continuing to push the envelope of ...
Breaking Medicine Technology:CytoSorbents to Report Q1 2015 Operating and Financial Results 2CytoSorbents to Report Q1 2015 Operating and Financial Results 3Concord Medical Services Announces 2015 Extraordinary General Meeting of Shareholders 2YOLO Medical Inc. receives FDA clearance for body contouring laser 2
... CTi Wrist is a custom wrist orthotic designed to ... patient's maximum range-of-motion. , ,Indications: , Wrist ... fibrocartilage complex , Coles fracture - distal ... Partial tendon rupture , ORIF - Open ...
The Contoured Wrist/Forearm Support provides comfort for post-surgical immobilization, post-fracture casting, and wrist sprains and strains....
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
ManuTrain is an active wrist support that has optional features for increased stabilization....
Medicine Products: